Clinical Trials Directory

Trials / Completed

CompletedNCT02636166

Project-0027. Lay User Usage Study

Project-0027 Lay User Usage Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
943 (actual)
Sponsor
SPD Development Company Limited · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Study volunteers will be required to conduct a home pregnancy test (HPT) at the trial centre and provide a sample of urine from the same void for further testing. Volunteers will then complete a product usage questionnaire and leaflet comprehension questionnaire at site. Follow-up information will be required from all volunteers as both additional urine sample(s) and pregnancy information to establish true pregnancy status at the study visit.

Detailed description

Eligible volunteers will be recruited into the study and provide informed consent. Volunteers will then test their urine sample with the investigational HPT according to the device Instructions for use and record their result onto the results sheet. A sample of urine from the same void will be obtained for further testing by the study technicians. The technician will then test the volunteer's sample with a second investigational HPT, a professional use pregnancy test and a Clearblue Digital HPT, the results of which will be used to provide the volunteer with her pregnancy test result. During technician testing, the volunteer will complete the device usability and leaflet comprehension questionnaires. At the end of the study visit, all volunteers will be provided with materials to allow follow-up for the determination of pregnancy status. The majority of volunteers will be requested to provide one additional urine sample, collected 2 days after the study visit. If early pregnancy is suspected the volunteer will be requested to provide an additional 7 daily urine samples following the study visit. All volunteers will be required to provide details of pregnancy status (documented menses or pregnancy confirmation by health care professional) after the study visit. True pregnancy status will be determined by laboratory tests and clinical information. The study will continue until a minimum of 300 pregnant and 300 not pregnant volunteers have completed the study.

Conditions

Interventions

TypeNameDescription
OTHERClearblue Investigational Pregnancy testClearblue Investigational Pregnancy test
OTHERProfessional pregnancy testAlere Professional use pregnancy test
OTHERClearblue Marketed Pregnancy testClearblue Marketed Pregnancy test

Timeline

Start date
2015-07-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2015-12-21
Last updated
2015-12-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02636166. Inclusion in this directory is not an endorsement.